79 results in Exploration of Digestive Diseases
Most Cited
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications
Zongmei Wu ... Han Moshage
Published: July 13, 2022 Explor Dig Dis. 2022;1:4–20
Open Access
Editorial
Extra-hepatic cancers in metabolic fatty liver syndromes
Amedeo Lonardo
Published: February 24, 2023 Explor Dig Dis. 2023;2:11–17
Open Access
Review
Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication
Elias Kouroumalis ... Argyro Voumvouraki
Published: April 16, 2024 Explor Dig Dis. 2024;3:107–142
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Jose M. Pinazo-Bandera ... Miren García-Cortés
Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
This article belongs to the special issue CHOLESTASIS
Open Access
Review
The central role of mitochondrial metabolism in hepatic steatosis
Sanda Win ... Filbert Win Min Aung
Published: February 29, 2024 Explor Dig Dis. 2024;3:42–68
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies
Amedeo Lonardo
Published: August 30, 2023 Explor Dig Dis. 2023;2:188–201
This article belongs to the special issue Advances in Hepato-gastroenterology: Diagnosis, Prognostication, and Disease Stratification
Open Access
Perspective
The intermicrovillar adhesion complex in gut barrier function and inflammation
Bernadette Mödl ... Robert Eferl
Published: October 11, 2022 Explor Dig Dis. 2022;1:72–79
Open Access
Review
SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers
Patrizia Pontisso, Maurizio Parola
Published: February 28, 2024 Explor Dig Dis. 2024;3:22–41
This article belongs to the special issue Fibrosis and Hepatobiliary Cancer
Open Access
Review
Alcohol-related liver disease: also a question of what you drink?
Finn Jung ... Ina Bergheim
Published: June 30, 2023 Explor Dig Dis. 2023;2:118–132
Open Access
Review
Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease—What are the proposed mechanisms?
Franziska A. Hägele ... Anja Bosy-Westphal
Published: August 24, 2023 Explor Dig Dis. 2023;2:133–148
Open Access
Review
Zebrafish as a model for drug induced liver injury: state of the art and beyond
Gulcin Cakan-Akdogan ... Ozlen Konu
Published: April 26, 2023 Explor Dig Dis. 2023;2:44–55
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Review
Helicobacter pylori infection and metabolic syndrome
Natalia V. Baryshnikova ... Alexander N. Suvorov
Published: September 10, 2024 Explor Dig Dis. 2024;3:414–427
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
Vicent Ribas
Published: June 14, 2024 Explor Dig Dis. 2024;3:203–225
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Fructose, a trigger of metabolic diseases?—a narrative review
Anja Baumann ... Ina Bergheim
Published: August 29, 2022 Explor Dig Dis. 2022;1:51–71
Open Access
Review
Etiopathogenesis and pathophysiology of cholestasis
Maitane Asensio ... Jose J. G. Marin
Published: October 31, 2022 Explor Dig Dis. 2022;1:97–117
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma
Chenyu Wei ... Xianguang Yang
Published: December 13, 2023 Explor Dig Dis. 2023;2:282–296
This article belongs to the special issue Cellular and Molecular Targets for NAFLD or MAFLD Treatments and Their Functions in Liver Fibrosis, Cirrhosis, and Cancer
Open Access
Review
Bile as a liquid biopsy matrix: potential applications and limitations
Maria Arechederra ... Carmen Berasain
Published: February 04, 2024 Explor Dig Dis. 2024;3:5–21
Open Access
Review
Liver injury related to Japanese herbal medicines: clinical features and diagnosis
Naoki Mantani
Published: June 27, 2023 Explor Dig Dis. 2023;2:77–82
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Review
Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury
Hanghang Wu ... Francisco Javier Cubero
Published: June 28, 2023 Explor Dig Dis. 2023;2:83–99
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Original Article
Human liver stem cell-derived extracellular vesicles modulate long non-coding RNA expression profile in an in vivo model of non-alcoholic steatohepatitis
Giulia Chiabotto ... Stefania Bruno
Published: August 30, 2023 Explor Dig Dis. 2023;2:172–187
Journal Information